Temozolomide for patients with cerebral metastases who have failed radiation therapy.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2010
At a glance
- Drugs Temozolomide (Primary)
- Indications Cancer metastases; Solid tumours
- Focus Therapeutic Use
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2005 New trial record.